Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Mass Screening × Clear all

NCT06612281 2024-11-14

Evaluation of Gixam's Performance in a FIT Negative Population

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms